The ICR’s scientists have access to state-of-the-art research technologies including in genomics, proteomics, flow cytometry, light and electron microscopy, tissue culture, and histology. They are leaders in the development of cancer research models, including mouse models, at its dedicated Biological Services Unit, and its scientists have access to high-specification in vivo imaging technologies via the Centre for Cancer Imaging in Sutton. In some circumstances, the ICR enables access to some of its platform technologies to companies with which it collaborates or which align with its mission to defeat cancer, on a fee-for-service basis – including companies already on site at The London Cancer Hub.​

The Royal Marsden is a world-leading cancer hospital. Its state-of-the-art facilities enable specialists to deliver the highest standards of care in comfortable and reassuring surroundings. It is continuously investing in its facilities to ensure patients receive the best possible treatment, care and experience. In Sutton, The Royal Marsden’s facilities include a large haematology practice, including stem cell transplants and car-T therapy, and its main molecular diagnostics laboratory – which is one of seven genomic laboratory hubs for NHS England, providing cancer testing for a population of around seven million people.​

In 2023, The Royal Marsden opened the state-of-the-art Oak Cancer Centre in Sutton – a major research and treatment facility that will help accelerate the development of new cancer treatments, diagnose more cancers at an earlier stage and enhance the treatment experience for patients.​

The Innovation Gateway is The London Cancer Hub’s science incubator. It is home to innovative spin-outs, start-ups and scale-ups working in MedTech / oncology, including, Vesynta, Vortex Biotech and Curesponse. It contains 6,300 square feet of laboratories, write-up space and shared facilities.​

In December 2023, London Borough of Sutton completed the long lease sale for development by Aviva and Socius of a five-hectare site adjacent to the ICR and The Royal Marsden. Aviva and Socius will develop one million ft² of research, treatment and innovation spaces alongside residential accommodation and amenities. It will be one of London’s most significant regeneration projects and once completed will make Sutton, and the capital, home to the world’s largest cancer life science district.

Epsom and St Helier University Hospitals NHS Trust have plans to build a Specialist Emergency Care Hospital on site as part of the Government’s £3.7 billion New Hospitals Programme. The hospital was announced by the Government in 2020.

The London Cancer Hub is also home to science specialist secondary school Harris Academy Sutton and Maggies at The Royal Marsden, which provides free practical, emotional and social support to people with cancer and their family and friends. Both have won prestigious architectural awards.